Literature DB >> 27233827

Corticosterone and dopamine D2/D3 receptors mediate the motivation for voluntary wheel running in C57BL/6J mice.

Mohamed Elsaed Ebada1, David A Kendall1, Marie-Christine Pardon2.   

Abstract

Physical exercise can improve cognition but whether this is related to motivation levels is unknown. Voluntary wheel running is a rewarding activity proposed as a model of motivation to exercise. To question the potential effects of exercise motivation on subsequent behaviour, we used a pharmacological approach targeting some reward mechanisms. The stress hormone corticosterone has rewarding effects mediated by activation of low affinity glucocorticoid receptors (GR). To investigate whether corticosterone synthesis motivates exercise via activation of GRs and subsequently, impacts on behaviour, we treated C57BL/6J mice acutely with the inhibitor of corticosterone synthesis metyrapone (35mg/kg) or repeatedly with the GR antagonist mifepristone (30mg/kg) prior to 1-h running wheel sessions. To investigate whether reducing motivation to exercise impacts on behaviour, we antagonised running-induced dopamine D2/D3 receptors activation with sulpiride (25 or 50mg/kg) and assessed locomotor, anxiety-related and memory performance after 20 running sessions over 4 weeks. We found that corticosterone synthesis contributes to running levels, but the maintenance of running behaviour was not mediated by activation of GRs. Intermittent exercise was not associated with changes in behavioural or cognitive performance. The persistent reduction in exercise levels triggered by sulpiride also had limited impact on behavioural performance, although the level of performance for some behaviours was related to the level of exercise. Altogether, these findings indicate that corticosterone and dopamine D2/D3 receptor activation contribute to the motivation for wheel running, but suggest that motivation for exercise is not a sufficient factor to alter behaviour in healthy mice.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C57BL/6J mice; Corticosterone; Dopamine D2/D3 receptors; Glucocorticoid receptors; Memory; Voluntary wheel running

Mesh:

Substances:

Year:  2016        PMID: 27233827     DOI: 10.1016/j.bbr.2016.05.051

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  5 in total

1.  Duration- and sex-dependent neural circuit control of voluntary physical activity.

Authors:  Margaret K Tanner; Jazmyne K P Davis; Jennifer Jaime; Nicolette A Moya; Alyssa A Hohorst; Kelsey Bonar; Kelsey A Abrams; Nashra Jamil; Rebecca Han; Troy J Hubert; Nadja Brown; Esteban C Loetz; Benjamin N Greenwood
Journal:  Psychopharmacology (Berl)       Date:  2022-10-04       Impact factor: 4.415

2.  Corticosterone level and central dopaminergic activity involved in agile and exploratory behaviours in formosan wood mice (Apodemus semotus).

Authors:  Kun-Ruey Shieh; Shu-Chuan Yang
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2018-03-27       Impact factor: 1.836

3.  Behavior of mice aboard the International Space Station.

Authors:  April E Ronca; Eric L Moyer; Yuli Talyansky; Moniece Lowe; Shreejit Padmanabhan; Sungshin Choi; Cynthia Gong; Samuel M Cadena; Louis Stodieck; Ruth K Globus
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

4.  Probiotic Supplementation and High-Intensity Interval Training Modify Anxiety-Like Behaviors and Corticosterone in High-Fat Diet-Induced Obesity Mice.

Authors:  Parisa Foroozan; Maryam Koushkie Jahromi; Javad Nemati; Hosein Sepehri; Mohammad Amin Safari; Serge Brand
Journal:  Nutrients       Date:  2021-05-21       Impact factor: 5.717

5.  Effects of high-intensity interval versus mild-intensity endurance training on metabolic phenotype and corticosterone response in rats fed a high-fat or control diet.

Authors:  Youqing Shen; Guoyuan Huang; Bryan P McCormick; Tao Song; Xiangfeng Xu
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.